Keywords: شدت دوز; Urothelial carcinoma; Transitional cell carcinoma; Muscle-invasive disease; Neoadjuvant chemotherapy; Dose intensity;
مقالات ISI شدت دوز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شدت دوز; BCR-ABL1; Chronic myeloid leukemia; Dose intensity; Philadelphia chromosome; Ponatinib; Tyrosine kinase inhibitor;
Keywords: شدت دوز; Nasopharyngeal carcinoma; Concurrent chemoirradiation; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Dose intensity
Survival Impact of CAPOX Versus FOLFOX in the Adjuvant Treatment of Stage III Colon Cancer
Keywords: شدت دوز; Colorectal; Duration; Dose intensity; Toxicity; XELOX;
Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
Keywords: شدت دوز; Castration-resistant prostate cancer; Cabazitaxel; Dosing schedule; Dose intensity;
Thiotepa 10 mg/kg Treatment Regimen Is Superior to Thiotepa 5 mg/kg in TBF Conditioning in Patients Undergoing Allogeneic Stem-Cell Transplantation
Keywords: شدت دوز; Dose intensity; Hematological malignancies; High risk; Reduced toxicity conditioning regimens;
Chimiothérapies dans le cancer colorectal : étude pragmatique des modifications de prescription et de dose intensité
Keywords: شدت دوز; Colorectal; Chimiothérapies; Prescription; Toxicité; Dose intensité; Colorectal; Chemotherapy; Prescription; Toxicity; Dose intensity;
Doxycycline for prevention of erlotinib-induced rash in patients with non-small-cell lung cancer (NSCLC) after failure of first-line chemotherapy: A randomized, open-label trial
Keywords: شدت دوز; doxycycline; erlotinib; folliculitis; non-small-cell lung cancer; rash; AE; adverse event; CI; confidence interval; CONSORT; CONsolidated Standards Of Reporting Trials; CTCAE; Common Terminology Criteria for Adverse Events; CYTAR; CYcline and TARceva; DI;
Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment
Keywords: شدت دوز; Adjuvant; dose intensity; dose reduction; predictors; resected NSCLC; time to adjuvant chemotherapy;
Defining dose-limiting toxicity for phase 1 trials of molecularly targeted agents: Results of a DLT-TARGETT international survey
Keywords: شدت دوز; Dose-limiting toxicity; Assessment period; Experts; Dose intensity; Phase 1; Recommended phase 2 dose
Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)
Keywords: شدت دوز; Ovarian cancer; Obesity; Chemotherapy dosing; Dose intensity; Overall survival; Progression free survival
Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer
Keywords: شدت دوز; Cisplatin; Paclitaxel; Weekly chemotherapy; Ovarian cancer; Dose intensity; Pharmacokinetics; Toxicity; Response
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Keywords: شدت دوز; Nasopharyngeal carcinoma; Head and neck cancer; Concurrent chemoradiotherapy; Cisplatin; Dose intensity; Prognostic factor
Individual dose and exposure of Italian children to ultrafine particles
Keywords: شدت دوز; Particle number concentration; Individual exposure; Children daily dose; Deposited surface area; Dose intensity;
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: Results of a GORTEC randomized trial
Keywords: شدت دوز; Radiotherapy; Chemotherapy; Dose intensity; Head and neck cancer;
A randomised phase II trial of 1 month versus 1 year of adjuvant high-dose interferon α-2b in high-risk acral melanoma patients
Keywords: شدت دوز; Acral melanoma; High-dose interferon α-2b; Dose intensity; Duration; Toxicity;
Modest Reductions in Dose Intensity and Drug-Induced Neutropenia have No Major Impact on Survival of Patients with Non-small Cell Lung Cancer Treated with Platinum-Doublet Chemotherapy
Keywords: شدت دوز; NSCLC; Dose intensity; Neutropenia; Dose reduction; Progression-free survival; Overall survival
Internet-based system for anti-tumor chemotherapy evaluation
Keywords: شدت دوز; Internet-based; Anti-tumor chemotherapy; Dose intensity; XML
Recent developments in the treatment of aggressive non-Hodgkin lymphoma
Keywords: شدت دوز; Non-Hodgkin lymphoma; Diffuse large B-cell lymphoma; CHOP; CHOEP; Rrituximab; Dose intensity; Dose dense; Dose densification; Granulocyte colony-stimulating factor
A Phase II Trial of Carboplatin/Vinorelbine with Pegfilgrastim Support for the Treatment of Patients with Advanced Non-small Cell Lung Cancer
Keywords: شدت دوز; Dose intensity; Growth factors; Cytokines; Lung cancer; Febrile neutropenia
Intensidad de dosis recibida en el tratamiento quimioterápico del cáncer de mama
Keywords: شدت دوز; Cáncer de mama; Intensidad de dosis; Reducción de dosis quimioterápica; Retraso de la dosis quimioterápica; Supervivencia global; Supervivencia libre de enfermedad; Neutropenia; Breast cancer; Dose intensity; Chemotherapy dose reduction; Chemotherapy
Evolving Role of Stem Cell Transplantation in Multiple Myeloma
Keywords: شدت دوز; Autologous transplantation; Bortezomib; Combination therapy; Dose intensity; Lenalidomide; Thalidomide;
Intensive Therapy before or during the Conditioning Regimen of Allogeneic Marrow Transplantation in Adult Acute Lymphoblastic Leukemia Patients: We Must Choose to Reduce Toxicity-A Groupe Ouest-Est d'Etude des Leucémies et Autres Maladies du Sang Study
Keywords: شدت دوز; Acute lymphoblastic leukemia; Allogeneic hematopoietic transplantation; Dose intensity; Toxicity; Treatment-related mortality;